Is OUTLOOK THERAPEUTICS INC (OTLK) overvalued? · P/E 0.4, rev $1.5M
OUTLOOK THERAPEUTICS INC (OTLK) is a biotechnology company listed on US.
This page asks whether OUTLOOK THERAPEUTICS INC (OTLK) looks expensive on cached numbers — not a short thesis.
Latest reported OTLK revenue for 2025-06-30 was $1.5M. Net income was -$20.2M. OTLK currently screens at market cap $68.6M and trailing P/E 0.4.
OTLK currently screens at market cap $68.6M and trailing P/E 0.4. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next OTLK 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the OTLK stock page for the full model, not this heading.
Not investment advice.